VIN en es it fr

VIN Brand names, VIN Analogs

VIN Brand Names Mixture

  • No information avaliable

VIN Chemical_Formula


VIN RX_link

VIN fda sheet

VIN msds (material safety sheet)

VIN Synthesis Reference

No information avaliable

VIN Molecular Weight

778.932 g/mol

VIN Melting Point

No information avaliable

VIN H2O Solubility

No information avaliable

VIN State




VIN Dosage Forms


VIN Indication

For the treatment of non-small-cell lung carcinoma

VIN Pharmacology

Vinorelbine is a vinca alkaloid antineoplastic agent used as a treatment for various cancers including breast cancer, Hodgkin's disease, Kaposi's sarcoma, and testicular cancer. The vinca alkaloids are structurally similar compounds comprised of 2 multiringed units, vindoline and catharanthine. The vinca alkaloids have become clinically useful since the discovery of their antitumour properties in 1959. Initially, extracts of the periwinkle plant (Catharanthus roseus) were investigated because of putative hypoglycemic properties, but were noted to cause marrow suppression in rats and antileukemic effects in vitro. Vinorelbine binds to the microtubular proteins of the mitotic spindle, leading to crystallization of the microtubule and mitotic arrest or cell death. Vinorelbine has some immunosuppressant effect. The vinca alkaloids are considered to be cell cycle phase-specific.

VIN Absorption

No information avaliable

VIN side effects and Toxicity

No information avaliable

VIN Patient Information

No information avaliable

VIN Organisms Affected

Humans and other mammals